Skip to main content
Mark Frohlich, MD, Oncology, Seattle, WA

MarkWalterFrohlichMD

Oncology • Seattle, WA

EVP R&D, Juno Therapeutics

Join to view full profile

Dr. Frohlich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Frohlich's full profile

Already have an account?

  • Office

    1951 E 120th St
    Apt 2
    Seattle, WA 44106
    Phone+1 206-744-3241

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1990 - 1994
  • Harvard Medical School
    Harvard Medical SchoolClass of 1990

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2002 - 2026

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • 18th Annual International Society for Cellular Therapy (ISCT) Meeting 
    International Society for Cellular Therapy, Seattle, Washington - 6/5/2012

Press Mentions

  • Register Now
    Register NowJuly 19th, 2024
  • NEUVOGEN Appoints Dr. Mark W. Frohlich, a World-Renowned Immunotherapy Expert to Its Board of Directors and Scientific Advisory Board
    NEUVOGEN Appoints Dr. Mark W. Frohlich, a World-Renowned Immunotherapy Expert to Its Board of Directors and Scientific Advisory BoardAugust 23rd, 2021
  • Survey: Hoosier Manufacturers Expect to Weather COVID Storm
    Survey: Hoosier Manufacturers Expect to Weather COVID StormNovember 19th, 2020
  • Join now to see all

Professional Memberships

Dr. Mark Frohlich, Dr. Mark Frohlich, MD, Dr. M Frohlich, Dr. Mark Walter Frohlich